Simplex Trading, LLC Chembio Diagnostics, Inc. Transaction History

Simplex Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.25 - $0.45 $3,950 - $7,110	-15,800 Reduced 88.58%	2,036 $0
Q4 2022 Feb 02, 2023	BUY	$0.2 - $0.33 $1,893 - $3,124	9,467 Added 113.12%	17,836 $3,000
Q3 2022 Nov 04, 2022	SELL	$0.35 - $1.1 $2,558 - $8,042	-7,311 Reduced 46.63%	8,369 $3,000
Q2 2022 Aug 03, 2022	SELL	$0.45 - $0.8 $5,220 - $9,280	-11,600 Reduced 42.52%	15,680 $10,000
Q1 2022 May 02, 2022	SELL	$0.66 - $1.23 $4,271 - $7,960	-6,472 Reduced 19.18%	27,280 $22,000
Q4 2021 Feb 23, 2022	BUY	$1.09 - $2.55 $30,185 - $70,617	27,693 Added 457.06%	33,752 $38,000
Q3 2021 Oct 28, 2021	SELL	$2.06 - $5.34 $976 - $2,531	-474 Reduced 7.26%	6,059 $17,000
Q2 2021 Aug 12, 2021	BUY	$2.88 - $5.64 $195 - $383	68 Added 1.05%	6,533 $19,000
Q1 2021 Apr 26, 2021	SELL	$3.4 - $7.97 $18,870 - $44,233	-5,550 Reduced 46.19%	6,465 $22,000
Q4 2020 Feb 02, 2021	BUY	$4.11 - $7.51 $32,621 - $59,606	7,937 Added 194.63%	12,015 $57,000
Q3 2020 Oct 14, 2020	BUY	$3.28 - $5.93 $12,034 - $21,757	3,669 Added 897.07%	4,078 $19,000
Q2 2020 Jul 13, 2020	BUY	$3.18 - $15.54 $1,300 - $6,355	409 New	409 $1,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.